Erinc H. is a highly accomplished researcher and academic currently serving as a Group Leader at Max Perutz Labs in Vienna and an Assistant Professor at the Medical University of Vienna and Harvard Medical School. With a focus on alpha-Synuclein pathogenesis in mammalian cell culture models of Parkinson's Disease, Erinc H. possesses extensive postdoctoral experience from prestigious institutions including Brigham and Women's Hospital and the Whitehead Institute for Biomedical Research. Scholarly training includes a PhD from Heidelberg University, complemented by postdoctoral studies at the Massachusetts Institute of Technology. Erinc H. has demonstrated a strong academic foundation with advanced degrees in Molecular Biology and Genetics from Middle East Technical University.
This person is not in any offices
Max Perutz Labs Vienna
The Max Perutz Labs are a joint venture between the University of Vienna and the Medical University of Vienna that builds on the unique opportunities that arise from being embedded in the Vienna BioCenter Campus while having one of the largest hospitals in Europe, the Vienna General Hospital, on our doorstep. In visualizing haemoglobin, Max Perutz paved the way towards the era of precision medicine. To realize its full potential, precision medicine necessitates a molecular mechanistic approach. Research at the Max Perutz Labs is curiosity-driven and spans the fields of molecular and cell biology. Most groups investigate basic research questions but a significant number are also active in more applied fields of biology. The Max Perutz Labs seek to educate students to think critically and analytically, challenge them to set ambitious goals, and instill in them both broad horizons and deep understanding. In doing so, we aspire to furnish them with the necessary knowledge and skills to push forward the frontiers of 21st century biomedical science.